Stock Events

Stock Events

SpectraCure AB (publ) 

0
0
+SEK0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-56.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SPEC-BT-UN.ST. It's not an investment recommendation.
Ovzon AB
2
OVZON.ST

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap133.83B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing in the broader field of innovative medical treatments for cancer.
Medtronic
MDT
Mkt Cap119.49B
Medtronic plc provides a variety of medical technologies, including cancer therapies, competing in the medical device sector like SpectraCure.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific Corporation develops medical devices that are used in various interventional medical specialties, competing with SpectraCure's therapeutic technologies.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. manufactures medical devices, including those for cancer treatments, competing with SpectraCure's medical device offerings.
Stryker
SYK
Mkt Cap126.37B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology, indirectly competing with SpectraCure's cancer therapies.
Globus Medical
GMED
Mkt Cap11.67B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores treatments in adjacent medical fields, potentially overlapping with SpectraCure's market.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie Inc. engages in biopharmaceutical research including oncology, which could compete with SpectraCure's photodynamic therapy for cancer treatment.

About

SpectraCure AB (publ) specializes in oncology, developing innovative cancer treatments that harness laser light and photodynamic agents. A cornerstone of their research is the IDOSE software, which powers an interstitial photodynamic therapy (PDT) system. This cutting-edge system is currently in Phase II clinical trials, where its efficacy in addressing solid tumors is being evaluated. The Swedish company, established in Lund in 2003, continues to advance its therapeutic solutions.
Show more...
CEO
Johannes Swartling
Employees
13
Country
Sweden
ISIN
SE0014428850

Listings

ST
SE
SPEC-BT-UN.ST
ST
SE
SPEC.ST
F
DE
2OK.F

0 Comments

Share your thoughts

FAQ

What is SpectraCure AB (publ) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange SpectraCure AB (publ) stocks are traded under the ticker SPEC-BT-UN.ST.
What is SpectraCure AB (publ) revenue for the last year?▼
SpectraCure AB (publ) revenue for the last year amounts to 0 SEK.
What is SpectraCure AB (publ) net income for the last year?▼
SPEC-BT-UN.ST net income for the last year is -56.08M SEK.
How many employees does SpectraCure AB (publ) have?▼
As of August 29, 2026, the company has 13 employees.
In which sector is SpectraCure AB (publ) located?▼
SpectraCure AB (publ) operates in the Health & Wellness sector.
When did SpectraCure AB (publ) complete a stock split?▼
SpectraCure AB (publ) has not had any recent stock splits.
Where is SpectraCure AB (publ) headquartered?▼
SpectraCure AB (publ) is headquartered in Lund, Sweden.